Dissertation_AndreaTuebbicke.pdf - Ernst-Moritz-Arndt-Universität ...

Van Hoecke, F., N. Deloof, et al. (2011). "Performance evaluation of a modified
chromogenic medium, ChromID MRSA New, for the detection of methicillinresistant
Staphylococcus aureus from clinical specimens." Eur J Clin Microbiol
Infect Dis.
van Loo, I. H., S. van Dijk, et al. (2007). "Evaluation of a chromogenic agar
(MRSASelect) for the detection of meticillin-resistant Staphylococcus aureus
with clinical samples in The Netherlands." J Med Microbiol 56 (Pt 4): 491-494.
van Rijen, M. M. and J. A. Kluytmans (2009). "Costs and benefits of the MRSA Search
and Destroy policy in a Dutch hospital." Eur J Clin Microbiol Infect Dis 28 (10):
1245-1252.
Van Vaerenbergh, K., R. Cartuyvels, et al. (2010). "Performance of a New
Chromogenic Medium, BBL CHROMagar MRSA II (BD), for Detection of
Methicillin-Resistant Staphylococcus aureus in Screening Samples." Journal of
Clinical Microbiology 48 (4): 1450-1451.
Voss, A. and B. Doebbeling (1995). "The worldwide prevalence of methicillin-resistant
Staphylococcus aureus." Int J Antimicrob Agents 5 (2 ): 101–106.
Vriens, M., H. Blok, et al. (2002). "Costs Associated with a Strict Policy to Eradicate
Methicillin-Resistant Staphylococcus aureus in a Dutch University Medical
Center: A 10-Year Survey." Eur J Clin Microbiol Infect Dis 21: 782–786.
Wagenvoort, J. H. T., M. F. H. A. van de Cruijs, et al. (2006). "Comparison of an
enrichment broth-enhanced commercial PCR procedure versus bacteriological
culture for separating non-colonized from suspected or colonized MRSA
individuals." Eur J Clin Microbiol Infect Dis 26: 155–160.
Warren, D. K., R. S. Liao, et al. (2004). "Detection of methicillin-resistant
Staphylococcus aureus directly from nasal swab specimens by a real-time PCR
assay." J Clin Microbiol 42 (12): 5578-5581.
Wassenberg, M. W. M., J. A. J. W. Kluytmans, et al. (2010). "Rapid screening of
methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a
prospective study to evaluate costs and effects." Clinical Microbiology and
Infection 16 (12): 1754-1761.
Weinstein, M. and H. Fineberg (1980). Clinical Decision Analysis. Philadelphia,
Saunders.
Wernitz, M. (2006). Screening bei stationärer Aufnahme von Risikopatienten für die
Kolonisation oder Infektion mit Methicillin-resistentem Staphylococcus aureus
(MRSA). Medizinischen Fakultät Berlin, Charité Universitätsmedizin 102.
Wernitz, M. H. (2006). Screening bei stationärer Aufnahme von Risikopatienten für die
Kolonisation oder Infektion mit Methicillin-resistentem Staphylococcus aureus
(MRSA) - eine Kohortenstudie über den Einfluss des Screenings auf die
Häufigkeit nosokomialer MRSA-Infektionen mit einer Kostenanalyse vor dem
Hintergrund des deutschen DRG-Fallpauschalen-Vergütungssystems -.
Medizinische Fakultät Berlin, Charité – Universitätsmedizin Berlin 107.
Wernitz, M. H., S. Keck, et al. (2005). "Cost analysis of a hospital-wide selective
screening programme for methicillin-resistant Staphylococcus aureus (MRSA)
carriers in the context of diagnosis related groups (DRG) payment." Clin
Microbiol Infect 11 (6): 466-471.
Wernitz, M. H., S. Swidsinski, et al. (2005). "Effectiveness of a hospital-wide selective
screening programme for methicillin-resistant Staphylococcus aureus (MRSA)
carriers at hospital admission to prevent hospital-acquired MRSA infections."
Clin Microbiol Infect 11 (6): 457-465.
XX